We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-1.4%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$45.6B
AUM Growth
-$2.97B
Cap. Flow
-$1.56B
Cap. Flow %
-3.42%
Top 10 Hldgs %
10.17%
Holding
4,085
New
718
Increased
950
Reduced
874
Closed
814

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$352M
2
KR icon
Kroger
KR
+$279M
3
T icon
AT&T
T
+$235M
4
INTC icon
Intel
INTC
+$217M
5
EW icon
Edwards Lifesciences
EW
+$212M

Sector Composition

Rank Sector Weight
1 Financials 19.08%
2 Technology 16.14%
3 Healthcare 15.45%
4 Consumer Discretionary 9.74%
5 Consumer Staples 5.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEI
3076
Solaris Energy Infrastructure
SEI
$2.97B
$185K ﹤0.01%
+19,828
New +$204K
INOD icon
3077
Innodata
INOD
$1.89B
$184K ﹤0.01%
60,829
+7,704
+15% +$33.6K
RTB
3078
RTB Digital
RTB
$240M
$184K ﹤0.01%
541
RUBY
3079
DELISTED
Rubius Therapeutics, Inc
RUBY
$184K ﹤0.01%
425,497
AJAX.WS
3080
CALL
DELISTED
Capri Listco Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exer
AJAX.WS
$184K ﹤0.01%
400,000
-91,507
-19% -$42.1K
GBIO
3081
DELISTED
Generation Bio
GBIO
$180K ﹤0.01%
3,382
-65
-2% -$4.07K
LMNR icon
3082
Limoneira
LMNR
$244M
$178K ﹤0.01%
13,588
-93,216
-87% -$1.22M
VERI icon
3083
Veritone
VERI
$98.5M
$178K ﹤0.01%
31,777
-209,866
-87% -$1.47M
FXE icon
3084
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
$177K ﹤0.01%
+1,964
New +$183K
SBUX icon
3085
CALL
Starbucks
SBUX
$117B
$176K ﹤0.01%
+2,100
New +$178K
AOGO
3086
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
$176K ﹤0.01%
17,678
SANA icon
3087
Sana Biotechnology
SANA
$910M
$175K ﹤0.01%
+29,180
New +$211K
AMPS
3088
DELISTED
Altus Power
AMPS
$175K ﹤0.01%
+15,834
New +$151K
UP.WS
3089
CALL
DELISTED
Wheels Up Experience Inc. Redeemable Warrants, each warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 per whole share of Common Stock
UP.WS
$175K ﹤0.01%
151,284
-32,747
-18% -$8.32K
CLIM.WS
3090
CALL
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
CLIM.WS
$175K ﹤0.01%
17,495
-17,500
-50% -$2.3K
CLSD
3091
DELISTED
Clearside Biomedical
CLSD
$173K ﹤0.01%
10,178
-4,343
-30% -$95.1K
SABSW icon
3092
CALL
SAB Biotherapeutics Warrant
SABSW
$73.4K
$173K ﹤0.01%
247,576
-37,424
-13% -$4.46K
EWY icon
3093
PUT
iShares MSCI South Korea ETF
EWY
$21.5B
$172K ﹤0.01%
3,600
-32,300
-90% -$1.84M
LMDXW
3094
CALL
DELISTED
LumiraDx Limited Warrant
LMDXW
$172K ﹤0.01%
168,400
-64,467
-28% -$21.4K
CAE icon
3095
CAE Inc. Common Shares
CAE
$8.48B
$169K ﹤0.01%
+11,033
New +$236K
LOW icon
3096
PUT
Lowe's Companies
LOW
$122B
$169K ﹤0.01%
+900
New +$175K
SMMT icon
3097
Summit Therapeutics
SMMT
$9.96B
$167K ﹤0.01%
+140,660
New +$159K
IDYA icon
3098
IDEAYA Biosciences
IDYA
$3.46B
$166K ﹤0.01%
+11,055
New +$144K
UBX
3099
DELISTED
Unity Biotechnology
UBX
$165K ﹤0.01%
41,046
-22,378
-35% -$141K
KLR
3100
DELISTED
Kaleyra, Inc.
KLR
$164K ﹤0.01%
48,037
-52,262
-52% -$344K

Similar funds

Marshall Wace's Q3 2022 Portfolio in Review

As of Q3 2022, Marshall Wace held 4,085 positions worth $45.6B, down 6.1% from $48.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace withdrew a net $1.56B in Q3 2022, closing 814 positions and reducing 874 holdings. Its most notable exit was General Dynamics, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Marshall Wace opened a new position in Albertsons Companies worth $84.6M.

  • Marshall Wace's largest Q3 2022 buy was Albertsons Companies: 3,404,097 shares worth $84.6M.
  • Marshall Wace added most to JPMorgan Chase in Q3 2022, an estimated $352M increase.
  • Marshall Wace's biggest Q3 2022 reduction was UnitedHealth, cutting an estimated $461M.
  • Marshall Wace fully exited General Dynamics in Q3 2022, selling an estimated $122M.
  • Marshall Wace's ten largest holdings make up 10% of its $45.6B portfolio in Q3 2022.
  • Marshall Wace opened 718 new positions and closed 814 in Q3 2022.
  • Marshall Wace's portfolio value fell 6.1% quarter-over-quarter to $45.6B.

Based on Marshall Wace's 13F filing for Q3 2022, filed 14 Nov 2022.